Tenaya Therapeutics Ratios (2020-2026) | TNYA

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-8,565.33%
EBIT Margin (Quarter)
-8,917.78%
EBITDA Margin (Quarter)
-8,917.78%
Operating Margin (Quarter)
-8,917.78%
Net Margin (Quarter)
-8,565.33%
FCF Margin (Quarter)
-8,343.56%
Efficiency
Assets Average (Quarter)
244.34M322.99M297.84M268.71M241.12M252.63M262.14M233.05M207.08M181.96M177.71M174.04M151.88M130.26M131.95M133.05M113.57M125.95M141.00M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-0.90-0.51-15.51-1.47-1.27-1.48-0.01M-25.64-8.52-1.95-23.35-25.35-1.57-1.47-19.91-27.84-1.60-1.49-21.94-9.78
Times Interest Earned (Quarter)
-0.90-0.51-15.51-1.47-1.27-1.48-0.01M-25.64-8.52-1.95-23.35-25.35-1.57-1.47-19.91-27.84-1.60-1.49-21.94-9.78
Valuation
Enterprise Value (Quarter)
-111.89M-280.46M-251.30M-210.45M-180.92M-149.45M-186.53M-147.81M-132.50M-121.75M-104.64M-122.25M-99.30M-79.47M-61.45M-88.16M-80.70M-56.30M-100.55M-80.90M
Return Ratios
Return on Sales (Quarter)
-0.86%
Return on Capital Employed (Quarter)
-24.70%-24.17%-32.59%-41.70%-52.48%-55.01%-52.79%-63.49%-71.55%-82.40%-82.77%-80.69%-90.45%-101.45%-93.15%-85.54%-96.86%-84.45%-69.12%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%